Chronic neutrophilic leukemia preceded by myelodysplastic syndromes

Int J Hematol. 2023 Nov;118(5):636-641. doi: 10.1007/s12185-023-03636-5. Epub 2023 Jul 13.

Abstract

Chronic neutrophilic leukemia (CNL) is primarily diagnosed by excluding myelodysplastic syndromes (MDS). We report the case of a patient who developed secondary CNL 3 years after hypoplastic MDS. We used droplet digital polymerase chain reaction mutation detection assay to analyze genomic alterations during the progression from MDS to CNL. At the time of MDS diagnosis, U2AF1 Q157P and SETBP1 D868N were dominant and additional mutation of ASXL1 1934_insG was observed. CSF3R T618I and SETBP1 D868N were increasing at the time of CNL diagnosis. We revealed the accumulation of multiple gene mutations during CNL development from MDS. This suggests that CNL was clonally developed from the founding clone of MDS and CSF3R mutation contributes to the development of CNL in the present case. These findings provide insights into the pathology of CNL.

Keywords: CSF3R; Chronic neutrophilic leukemia; Myelodysplastic syndromes.

Publication types

  • Case Reports

MeSH terms

  • Humans
  • Leukemia, Neutrophilic, Chronic* / complications
  • Leukemia, Neutrophilic, Chronic* / diagnosis
  • Leukemia, Neutrophilic, Chronic* / genetics
  • Mutation
  • Myelodysplastic Syndromes* / complications
  • Myelodysplastic Syndromes* / genetics